Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.

Clin Exp Dermatol

Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.

Published: April 2022

We report on a patient who presented with refractory subacute cutaneous lupus erythematosus. The scaly annular and polycyclic patches/plaques, and hyperkeratotic lesions on multiple fingers improved rapidly after treatment with baricitinib.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ced.15005DOI Listing

Publication Analysis

Top Keywords

refractory subacute
8
lupus erythematosus
8
treatment refractory
4
subacute cuataneous
4
cuataneous lupus
4
erythematosus baricitinib
4
baricitinib report
4
report patient
4
patient presented
4
presented refractory
4

Similar Publications

Cholesterol ester storage disease (CESD) is a rare autosomal recessive lysosomal storage disorder caused by mutations in the LIPA gene, leading to reduced lysosomal acid lipase activity, cholesterol ester accumulation, and systemic manifestations including liver dysfunction and dyslipidemia. We report the case of a 25-year-old male presenting with subacute jaundice, hyperbilirubinemia (total bilirubin 51 mg/dL, predominantly direct), and dyslipidemia characterized by elevated total cholesterol and low HDL cholesterol levels. Initial diagnostic workup for acute hepatitis and liver dysfunction, including serological and imaging studies, was unremarkable.

View Article and Find Full Text PDF

A man in his 60s suffered from refractory, biopsy-proven subacute cutaneous lupus erythematosus that required chronic, moderate dose steroids to manage. His rash was accompanied by arthralgias and negative autoantibody testing. His subacute lupus erythematosus (SCLE) was responsive to tofacitinib, but thrombotic complications limited the use of this medication.

View Article and Find Full Text PDF

Prevalence and causes of subacute cough in Japan.

Respir Investig

January 2025

Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, 1 Kawazumi Mizuho-machi, Nagoya, 467-860, Japan.

Article Synopsis
  • Subacute cough is a specific type of cough lasting 3-8 weeks and is primarily caused by cough variant asthma, atopic cough, and sinobronchial syndrome, rather than post-infectious cough as previously believed.
  • In a study involving 148 patients, 68.3% developed chronic cough, often stemming from multiple underlying conditions such as cough variant asthma combined with atopic cough.
  • The findings highlight the need for careful diagnosis and treatment of multiple causes in patients with subacute cough to prevent progression to chronic cough.
View Article and Find Full Text PDF

Adrenocortical Carcinoma: A Challenging Diagnosis.

Cureus

October 2024

Internal Medicine, Unidade Local de Saúde Viseu Dão-Lafões, Viseu, PRT.

Adrenocortical carcinoma (ACC) is a rare malignancy with aggressive behaviour and a poor prognosis. Patients can present with adrenal hormonal excess or with nonspecific symptoms driven by the presence of an abdominal mass or metastatic disease. Many are completely asymptomatic and diagnosed incidentally.

View Article and Find Full Text PDF

Neuroplasticity therapy using glia-like cells derived from human mesenchymal stem cells for the recovery of cerebral infarction sequelae.

Mol Ther

January 2025

Laboratory of Stem Cell & Neurobiology, Department of Oral Anatomy and Dental Research Institute, Seoul National University School of Dentistry, Seoul 03080, Republic of Korea; Interdisciplinary Program in Neuroscience, Seoul National University College of Natural Sciences, Seoul 08826, Republic of Korea; Neuroscience Research Institute, Seoul National University, Seoul 03080, Republic of Korea. Electronic address:

Article Synopsis
  • This study explores using human mesenchymal stem cells (hMSCs) transformed into glia-like cells (ghMSCs) to improve recovery after ischemic strokes, which cause brain damage.
  • Transcriptome analysis shows that ghMSCs behave like astrocytes and demonstrate better protective and regenerative qualities against brain injury than regular hMSCs.
  • In rat models, transplanting ghMSCs improved behavioral function and reduced brain damage, with their effectiveness linked to CXCR2 signaling, suggesting a potential therapy for stroke recovery by promoting neuroplasticity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!